𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Impact of TP53 and KRAS mutations on cisplatin-based adjuvant chemotherapy in non-small-cell lung cancer

✍ Scribed by X. Ma; E. Brambilla; J.C. Soria; A. Dunant; A.L. Vataire; P. Hainaut; the IALT-Bio study group


Book ID
119598802
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
85 KB
Volume
6
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES